Amit Kakar

Managing Partner at Novo Holdings · Joined 2020

View Live Interactive Profile →

Biography

Amit Kakar joined Novo Holdings Asia in August 2020 as Head of Asia and is Managing Partner, sitting on the firm's Life Science Leadership Team. He leads investments and partnerships across the region, focusing on China, Japan, Singapore and Southeast Asia. Novo Holdings says he has more than 25 years of healthcare experience with senior management roles in India, China, Singapore and the United States. He was previously with Everlife Asia in Singapore as Head of M&A and Business Development, with Avenue Capital Group as Head of healthcare investments for Asia and with GE Healthcare in several senior leadership positions. He is a medical doctor with a postgraduate degree in radiation and nuclear medicine from Tata Memorial Hospital and Cancer Centre in Mumbai.

Education

Previous Experience

Notable Investments

MedGenomeSurya HospitalsSCHOTT PoonawallaSylvan

Board Seats

Career Timeline

2020
Joins Novo Holdings Asia in August 2020 as Head of Asia.
2025
Identified as Chairman of the Board of MedGenome in the announcement of MedGenome's Series E funding co-led by Novo Holdings.
2026
Named in Novo Holdings' announcement that he will join the board of directors of Surya Hospitals.

Sources & References

Novo Holdings - Amit Kakar (people page, checked 6 September 2026) ↗MedGenome raises Series E funding co-led by Maj Invest and Novo Holdings (21 July 2025) ↗Novo Holdings invests in Surya Hospitals (20 January 2026) ↗Novo Holdings announces investment in SCHOTT Poonawalla (14 May 2025) ↗